To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01256736 · COMPLETED
Trial details
- NCT number
- NCT01256736
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-12-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.